A Study to Evaluate the Efficacy of Bicalutamide With Dose Escalated External Beam Radiotherapy (DE-EBRT) versus DE-EBRT in Patients With Localized Prostate Cancer

Trial Profile

A Study to Evaluate the Efficacy of Bicalutamide With Dose Escalated External Beam Radiotherapy (DE-EBRT) versus DE-EBRT in Patients With Localized Prostate Cancer

Discontinued
Phase of Trial: Phase II

Latest Information Update: 23 Jun 2016

At a glance

  • Drugs Bicalutamide (Primary)
  • Indications Prostate cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Jun 2016 New trial record
    • 24 May 2016 Primary endpoint has not been met. (Biochemical failure incidence), as per results published in the Cancer.
    • 24 May 2016 Results published in the Cancer
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top